Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Remed Co., Ltd. (302550:KRX), powered by AI.
Remed Co., Ltd. is currently trading at ₩2,970. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Remed Co., Ltd. on Alpha Lenz.
Remed Co., Ltd.'s P/E ratio is 174.4.
“Remed Co., Ltd. trades at a P/E of 174.4 (premium valuation) with modest ROE of 1.3%.”
Ask for details →Remed Co., Ltd., a prominent company in the healthcare sector, primarily focuses on the development and manufacture of medical devices and health solutions. The company's core operations include designing advanced medical equipment, such as electromagnetic stimulators, which are pivotal in physiotherapy and pain management. Remed Co., Ltd. has carved a niche in the market by integrating advanced technology into their medical devices, addressing the needs of both healthcare professionals and patients. With a significant emphasis on research and development, the company continually innovates to enhance the efficacy and accessibility of its products. Remed Co., Ltd. plays a crucial role in improving patient care standards globally, serving hospitals, clinics, and wellness centers. Building a strong market presence, the company contributes to advancing medical technology through its diverse portfolio, thereby supporting the healthcare industry's growth and evolution.
“Remed Co., Ltd. trades at a P/E of 174.4 (premium valuation) with modest ROE of 1.3%.”
Ask for details →Remed Co., Ltd. (ticker: 302550) is a company listed on KRX in the Healthcare sector (Medical Devices). It has approximately 89 employees. Market cap is $91.8B.
The current price is ₩2,970 with a P/E ratio of 174.45x and P/B of 2.29x.
ROE is 1.31% and operating margin is 2.96%. Annual revenue is $24.5B.